Jill Hagel's Insider Trades & SAST Disclosures

Jill Hagel's most recent trade in Enveric Biosciences Inc was a trade of 12,000 Common Stock done . Disclosure was reported to the exchange on Jan. 25, 2023.

Share

Note

This is a custom search result for pattern Jill Hagel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Enveric Biosciences Inc	Jill Hagel	Vice President of Innovation	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2023	12,000	35,802 (1%)	0%		0	Common Stock
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Oct 2021	10,500	23,802 (0%)	0%		0	Common Stock
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Oct 2021	1,021	13,302 (0%)	0%		0	Common Stock
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2021	531,602	531,602 (17%)	17%		-	Common Stock
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2021	531,602	531,602	-		-	Common Warrants
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2021	99,675	99,675	-		-	Stock Options
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2021	82,398	82,398 (2%)	2%		-	Common Stock
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2021	79,740	79,740	-		-	Common Warrants
Enveric Biosciences Inc	Jill Hagel	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2021	1,329	1,329	-		-	Common Warrants

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades